Evidence map›Paper›PMID 21080247›Full record

ReviewCurrent gastroenterology reports2011

Quality of care in inflammatory bowel disease.

Brijen Shah, Andrew Tinsley, Thomas Ullman

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current gastroenterology reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Brijen ShahMount Sinai School of Medicine, New York, NY 10029, USA.
Andrew Tinsley
Thomas Ullman
Icahn School of Medicine at Mount Sinai · US

Funding

Preventing Neoplastic Progression in Ulcerative ColitisK08DK069393 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI ULLMAN, THOMAS A · 2005 to 2009
$643k
NIDDK NIH HHS K-08- DK069393
6 · The paper itself

Abstract

Advances in the treatment of inflammatory bowel disease (IBD) are published routinely in medical journals. Some treatments are sufficiently helpful that their conclusions are incorporated into clinical guidelines. However, such publications and proclamations may go unheeded among practitioners. Underuse, overuse, and misuse of clinical therapeutics, diagnostics, and routine medical processes are sufficiently prevalent among IBD practitioners that movements are afoot to determine the best methods for achieving a minimal uniformity of effective care. Such explorations are part of an effort to improve the quality of care. In this article, we review the background that has led to a push toward quality improvements in medicine in general, in gastroenterology in general, and within IBD specifically.

Indexed as

Quality of Health CareChronic DiseaseGastroenterologyHumansInflammatory Bowel DiseasesModels, TheoreticalOutcome Assessment, Health CarePractice Guidelines as TopicPractice Patterns, Physicians'Quality Improvement

Identifiers

PMID21080247
OpenAlexW2041690989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.